Bruker (BRKR) News Today

Vanguard Group Inc. lowered its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 0.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,860,449 shares of the medical researc

Orion Portfolio Solutions LLC raised its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 93.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 50,522 shares of the medical res

Bruker Co. (NASDAQ:BRKR - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for shares of Bruker in a research report issued on Thursday, July 18th. Leerink Partnrs analyst P. Souda expects that the medical research company will post ea

TD Asset Management Inc raised its stake in Bruker Co. (NASDAQ:BRKR - Free Report) by 7.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,788,763 shares of the medical research company's stock aft

Bruker Co. (NASDAQ:BRKR - Free Report) - Zacks Research dropped their Q2 2024 earnings per share estimates for Bruker in a note issued to investors on Wednesday, July 17th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $0.54

Swiss National Bank lessened its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 12.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 177,600 shares of the medical research company's stock after selling 25,000 shares during the period

Susquehanna Fundamental Investments LLC bought a new stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 8,100 shares of the medical research company's sto

Bruker Co. (NASDAQ:BRKR - Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 3,530,000 shares, a growth of 35.8% from the June 15th total of 2,600,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the days-to-cover ratio is currently 2.9 days. Currently, 3.4% of the company's shares are sold short.

BNP Paribas Financial Markets lessened its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 66.2% in the first quarter, according to its most recent filing with the SEC. The firm owned 63,570 shares of the medical research company's stock after selling 124,631 shares during the quart

Norden Group LLC lifted its stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 2,039.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 89,655 shares of the medical research company's stock

Vaughan Nelson Investment Management L.P. increased its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 5.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 332,728 shares of the medical research company's

Congress Wealth Management LLC DE increased its position in Bruker Co. (NASDAQ:BRKR - Free Report) by 21.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 162,191 shares of the medical research company's stock after purchasing an additi

Bruker Co. (NASDAQ:BRKR - Get Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 2,600,000 shares, a drop of 39.3% from the May 31st total of 4,280,000 shares. Currently, 2.6% of the shares of the stock are short sold. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is currently 2.3 days.

Vanguard Group Inc. reduced its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 4.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,896,786 shares of the medical research company's stock aft

Congress Asset Management Co. MA increased its stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 3.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,414,362 shares of the medical research

American International Group Inc. trimmed its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 9.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 126,298 shares of the medical research company's stock after selling

Nomura Holdings Inc. acquired a new stake in Bruker Co. (NASDAQ:BRKR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 76,122 shares of the medical research company's stock, valued at approximately $5,593,0

Congress Asset Management Co. MA increased its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 11.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,367,061 shares of the medical research company's stock after acquiring an additional 139,822 shares d

Iron Triangle Partners LP grew its position in Bruker Co. (NASDAQ:BRKR - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 450,000 shares of the medical research company's stock after

Point72 Europe London LLP acquired a new stake in Bruker Co. (NASDAQ:BRKR - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 134,000 shares of the medical research company's stock, valued at approxim

Lighthouse Investment Partners LLC acquired a new stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 45,807 shares of the medical resear

RTW Investments LP reduced its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 1.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,344,095 shares of the medical research company's stock after selling 37,608 shares during the period. Br

Public Employees Retirement Association of Colorado raised its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 925.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 362,035 shares of the medical research compan

Rhenman & Partners Asset Management AB bought a new stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 16,000 shares of the medical research company's stock, valued at approximately $

Brown Brothers Harriman & Co. increased its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 117.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 260,574 shares of the medical research company's stock after acquiring an additional 140,724 sha

Bruker Co. (NASDAQ:BRKR - Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 4,100,000 shares, a growth of 27.3% from the April 30th total of 3,220,000 shares. Based on an average daily volume of 954,200 shares, the short-interest ratio is currently 4.3 days. Currently, 4.3% of the shares of the stock are short sold.

Bruker (NASDAQ:BRKR) Shares Gap Down to $72.55

TD Asset Management Inc raised its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 51.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,664,779 shares of the medical research company's s

Norges Bank acquired a new stake in Bruker Co. (NASDAQ:BRKR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,014,991 shares of the medical research company's stock, valued at approximately $74,

Trexquant Investment LP lifted its stake in Bruker Co. (NASDAQ:BRKR - Free Report) by 1,092.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 43,464 shares of the medical research company's stock after purchasing an additional 3

Dimensional Fund Advisors LP lessened its stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,170,777 shares of the medical research company's stock after selling 21,409 sh

Amalgamated Bank trimmed its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 20.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,233 shares of the medical research company's stock aft

Bruker Co. (NASDAQ:BRKR - Free Report) - Research analysts at Leerink Partnrs decreased their Q3 2024 earnings per share (EPS) estimates for Bruker in a report issued on Monday, May 20th. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will post earnings of $0.71

StockNews.com downgraded Bruker from a "buy" rating to a "hold" rating in a research report on Tuesday.